Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Speckle Tracking for Timing of Surgical Operation in Severe Mitral Regurge

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03156972
Recruitment Status : Recruiting
First Posted : May 17, 2017
Last Update Posted : May 17, 2017
Sponsor:
Information provided by (Responsible Party):
Mohammed mahmoud mohammed othman, Assiut University

Brief Summary:
Rhumatic heart disease patients with mitral regurge untile know had adibat for timming of surgical interferance our study aim to solve this problme using a new technic in echocardiography called speckle tracking which is more accurate in estimating a changes occure to myocyte of the heart and so chosing the proper time for surgery

Condition or disease Intervention/treatment Phase
Rheumatic Heart Disease Procedure: Replacment of mitral valve Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Assessment of Rheumatic Heart Disease Patients With Chronic Severe Mitral Regurge by Speckle Tracking Echocardiography for Proper Timing of Surgical Operation.
Actual Study Start Date : April 1, 2017
Estimated Primary Completion Date : April 1, 2018
Estimated Study Completion Date : August 1, 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Diseases

Arm Intervention/treatment
Active Comparator: Group a Procedure: Replacment of mitral valve
Mitral valve replacment by prothsis

Active Comparator: Group b Procedure: Replacment of mitral valve
Mitral valve replacment by prothsis




Primary Outcome Measures :
  1. Timing of surgical operation in patients with chronic severe mitral regurge [ Time Frame: One year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   13 Years to 70 Years   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • rhuematic heart disease with severe mitral regurge

Exclusion Criteria:

  • non rheumatic mitral regurge

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03156972


Contacts
Layout table for location contacts
Contact: Mohammed Dr Othman, Master 01002748383 ext 002 Ossman231@yahoo.com

Locations
Layout table for location information
Egypt
Assiut university Recruiting
Assiut, Egypt
Contact: Mohammed Mr Ahmed atef    01208083083 ext 002      
Sponsors and Collaborators
Mohammed mahmoud mohammed othman
Investigators
Layout table for investigator information
Principal Investigator: Mohammed Aly, Prof Assiut University

Layout table for additonal information
Responsible Party: Mohammed mahmoud mohammed othman, Assessment of rheumatic heart disease patients with chronic severe mitral regurge by Speckle Tracking Echocardiography for proper timing of surgical operation, Assiut University
ClinicalTrials.gov Identifier: NCT03156972     History of Changes
Other Study ID Numbers: Ossman231speckle
First Posted: May 17, 2017    Key Record Dates
Last Update Posted: May 17, 2017
Last Verified: May 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Diseases
Rheumatic Diseases
Rheumatic Heart Disease
Cardiovascular Diseases
Musculoskeletal Diseases
Connective Tissue Diseases
Rheumatic Fever
Streptococcal Infections
Gram-Positive Bacterial Infections
Bacterial Infections